Suppr超能文献

全球淋病奈瑟菌分离株对超广谱头孢菌素耐药性的时间和地理趋势:一项系统评价和荟萃分析

Temporal and geographic trends in extended-spectrum cephalosporins resistance among Neisseria gonorrhoeae isolates worldwide: a systematic review and meta-analysis.

作者信息

Alhusseini Laith B, Hasani Bita, Jaafar Firas Nabeeh, Beig Masoumeh, Abbasian Sara, Azizian Khalil

机构信息

Department of Ecology, College of Science, Kufa University, Kufa, Najaf, Iraq.

Department of Microbiology, Islamic Azad University, Tonekabon, Iran.

出版信息

BMC Infect Dis. 2025 Sep 29;25(1):1175. doi: 10.1186/s12879-025-11601-2.

Abstract

The global emergence of antibiotic resistance in Neisseria gonorrhoeae (NG) infections poses a critical public health challenge. This study aimed to evaluate global resistance rates to extended-spectrum cephalosporins (ESCs) in N. gonorrhoeae, considering factors such as time, geography, antimicrobial susceptibility testing (AST), and resistance interpretation. A systematic review and meta-analysis (from 1988 to 2025) of 252 studies from 71 countries reported a weighted pooled resistance rate (WPR) of ≤ 2.5% for ESCs. Significant temporal variation in ESCs-resistant isolates (P < 0.05) underscores the dynamic nature of resistance development. Significantly, there was a difference in penicillin resistance rates between countries/ continents, and AST (P < 0.001). These findings emphasize the urgent need for effective antimicrobial stewardship, enhanced contact tracing, and comprehensive monitoring systems to combat antimicrobial resistance in gonococcal infections.

摘要

淋病奈瑟菌(NG)感染中抗生素耐药性在全球范围内的出现构成了一项严峻的公共卫生挑战。本研究旨在评估淋病奈瑟菌对超广谱头孢菌素(ESCs)的全球耐药率,同时考虑时间、地理、抗菌药物敏感性试验(AST)以及耐药性解读等因素。一项对来自71个国家的252项研究进行的系统评价和荟萃分析(时间跨度为1988年至2025年)报告称,ESCs的加权合并耐药率(WPR)≤2.5%。耐ESCs分离株存在显著的时间变化(P<0.05),这突出了耐药性发展的动态性质。值得注意的是,不同国家/大洲之间的青霉素耐药率以及AST存在差异(P<0.001)。这些发现强调了迫切需要有效的抗菌药物管理、加强接触者追踪以及全面的监测系统,以对抗淋球菌感染中的抗菌药物耐药性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验